Hot Topic Symposium II: Managing Engineered T Cell Toxicities

The SITC 2014 Hot Topic Symposia Presentation Archive is supported through a generous contribution from Prometheus Laboratories Inc.

Access slide decks and video via the links in the schedule below.

PDF = click on presentation title to view .pdf version of slides.

VIDEO = presentation video is available. Click on the icon to view video. (Note: if no .pdf version is available for a given presentation, video will be linked from the presentation title.)

Sunday, November 9, 2014

10:30 am – 10:35 am Welcome and Overview  PDF  VIDEO
Kristen M. Hege, MD – Celgene Corporation and University of California, San Francisco
10:35 am – 10:45 am FDA – History of Immune-Related Adverse Effects from the Regulatory Perspective  PDF
Bindu George, MD – U.S. Food and Drug Administration
10:45 am – 10:55 am Toxicity and Management after CTL019 Therapy: Update from University of Pennsylvania  PDF
David L. Porter, MD – University of Pennsylvania
10:55 am – 11:05 am Anti-CD19 CAR T Cells: The Balance of Efficacy and Toxicity  PDF  VIDEO
James N. Kochenderfer, MD – National Cancer Institute
11:05 am – 11:15 am Memorial Sloan-Kettering Cancer Center Experience
Jae H. Park, MD – Memorial Sloan-Kettering Cancer Center
11:15 am – 11:25 am Fred Hutchinson Cancer Research Center Experience  PDF  VIDEO
Michael C.V. Jensen, MD – University of Washington
11:25 am – 11:35 am Cytokine Storm in T Cell Studies - An Update from Baylor University  PDF  VIDEO
Helen E. Heslop, MD – Baylor College of Medicine
11:35 am – 12:00 pm Panel Discussion

The SITC Hot Topic Symposia are non-accredited continuing medical education events. No credits are offered
for physician participation in these educational programs.

Creative Commons License
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.